Age, median | 37 |
Male, n (%) | 124 (67.0%) |
Aboriginal and/or Torres Strait Islander (ASTI), n (%) | 8 (4.3%) |
Blood borne viruses, n (%) | |
HIV | 1 (0.5%) |
Hep B sAg pos | 1 (0.5%) |
Hep C antibody pos Hep C antibody pos (2010–2015) Hep C antibody pos (2016–2021) | 106/185 (57.3%) 47/83 (51.8%) 59/102 (57.8%) |
Hep C PCR pos Hep C PCR pos (2010–2015) Hep C PCR pos (2016–2021) | 88/185 (47.6%) 43/83 (51.8%) 45/102 (44.1%) |
Primary drug of choice, n (%) | |
Opioid | 124 (67.0%) |
Amphetamine type stimulant (ATS) | 69 (47.6%) |
Other/unknown | 13 (7.0%) |